The downregulation of ZFP36 in NASH is not only involved in the “JAK-STAT pathway” and “TGF-βpathway” associated with inflammation regulation but also inhibits immune infiltration and promotes inflammation progression. Here, ZFP36 is linked to metabolic dysfunction-associated steatohepatitis.